Announcements Trials
Browse Landscape

Phase

Phase 2 59Phase 3 24Phase 2/3 6Phase NA 4Phase 1/2 4Phase 1 3Phase 4 2

Status

Unknown 5Completed 1

Sponsor Class

OTHER 4OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Colorectal Neoplasms 2Colonic Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Peripheral Nervous System Diseases 1Neoplasm Metastasis 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2/3 × XELOX × Clear all
NCT03957733 2022-04-06

Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.

King Abdullah Medical City

Phase 2/3 Unknown
338 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03031444 2021-02-01

PARECEC

Peking University Cancer Hospital & Institute

Phase 2/3 Completed
135 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT03399253 2018-01-16

Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

Sun Yat-sen University

Phase 2/3 Unknown
120 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02777437 2016-05-19

Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer

Fudan University

Phase 2/3 Unknown
1,960 enrolled
Gastrointestinal

Colonic Neoplasms

NCT02590367 2015-12-02

Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy

Jiangsu Province Hospital of Traditional Chinese Medicine

Phase 2/3 Unknown
64 enrolled
Gastrointestinal

Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT02510118 2015-08-03

Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients

Nanjing NingQi Medicine Science and Technology Co., Ltd.

Phase 2/3 Unknown
360 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡